Successful treatment with afatinib following the failure of osimertinib rechallenge with osimertinib-induced interstitial lung disease: A case report

Herein, we report the case of an 84-year-old woman with epidermal growth factor receptor (EGFR) mutation exon 19 deletion postoperative recurrent lung adenocarcinoma. Osimertinib was administered as a first-line treatment; however, she was urgently admitted to our hospital due to dyspnea on the 46th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Yozo, Sekine, Akimasa, Hagiwara, Eri, Sato, Midori, Yamaya, Takafumi, Asaoka, Masato, Higa, Katsuyuki, Ikeda, Satoshi, Baba, Tomohisa, Komatsu, Shigeru, Iwasawa, Tae, Ogura, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349001/
https://www.ncbi.nlm.nih.gov/pubmed/34401289
http://dx.doi.org/10.1016/j.rmcr.2021.101450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349001/
https://www.ncbi.nlm.nih.gov/pubmed/34401289
http://dx.doi.org/10.1016/j.rmcr.2021.101450

Ejemplares similares